69616-272 : Fycompa 2 mg Oral Tablet


NDC: 69616-272
Labeler: Catalyst Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Fycompa
Dosage Form: Oral Tablet
Application #: NDA202834
Rev. Date: 
CSA Schedule: CIII (US) [1]


[1] Schedule III / IIIN Controlled Substance: Has a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. (i.e. Products containing not more than 90 milligrams of Codeine per dosage unit [such as Tylenol with Codeine], other narcotics such as Buprenorphine (Suboxone), and Schedule IIIN non-narcotics such as Didrex, Ketamine, Phendimetrazine, and Anabolic Steroids). More Details: US Dept of Justice Controlled Substance Schedules.

NDC Package Codes:

  • 69616-272-14: 14 TABLET IN 1 PACKAGE (69616‑272‑14)
  • 69616-272-30: 30 TABLET IN 1 BOTTLE (69616‑272‑30)
  • 69616-272-90: 90 TABLET IN 1 BOTTLE (69616‑272‑90)

Active Ingredients:

  • Perampanel

Dosage Strength:

  • 2 mg

Pharmaceutical Classes:

  • AMPA Receptor Antagonists [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]
  • UGT1A9 Inhibitors [MoA]
  • UGT2B7 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 69616-274 Fycompa 4 mg Oral Tablet by Catalyst Pharmaceuticals, Inc.
  • 69616-276 Fycompa 6 mg Oral Tablet by Catalyst Pharmaceuticals, Inc.
  • 69616-278 Fycompa 8 mg Oral Tablet by Catalyst Pharmaceuticals, Inc.
  • 69616-280 Fycompa 10 mg Oral Tablet by Catalyst Pharmaceuticals, Inc.
  • 69616-282 Fycompa 12 mg Oral Tablet by Catalyst Pharmaceuticals, Inc.
  • 69616-290 Fycompa .5 mg/ml Oral Suspension by Catalyst Pharmaceuticals, Inc.
  • 62856-270 Fycompa 2-week Sample Pack Kit by Eisai Inc.
  • 62856-272 Fycompa 2 mg Oral Tablet by Eisai Inc.
  • 62856-274 Fycompa 4 mg Oral Tablet by Eisai Inc.
  • 62856-276 Fycompa 6 mg Oral Tablet by Eisai Inc.
  • 62856-278 Fycompa 8 mg Oral Tablet by Eisai Inc.
  • 62856-280 Fycompa 10 mg Oral Tablet by Eisai Inc.
  • 62856-282 Fycompa 12 mg Oral Tablet by Eisai Inc.
  • 62856-290 Fycompa .5 mg/ml Oral Suspension by Eisai Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69616-272 QR Code

< Prev: 69616-264Next: 69616-274 >

Related Discussions:

Seems Fycompa is causing more seizures.
My daughter is now on five different anti epileptics, last one added was Fycompa and everything has gotten worse. Many m... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.